Key Takeaways
- • Core Scientific (NASDAQ: CORZ) experienced stock price declines as a broad Bitcoin selloff pressured crypto-linked equities, with Bitcoin sliding to near four-month lows below $80,000 and subsequently to the mid-$60,000 range.
- • Core Scientific held approximately 2,537 bitcoins as of December 31, 2025, but the company had been actively liquidating its Bitcoin holdings, with fewer than 1,000 BTC remaining as of early 2026 and plans to sell the remainder during Q1 2026 to increase liquidity.
- • The decline in Core Scientific's stock price reflects both the company's direct exposure to Bitcoin price movements and investor concerns regarding its fourth-quarter revenue decline, despite management's push toward AI and HPC (high-performance computing) colocation services.
- • Crypto-adjacent equities including Coinbase, MicroStrategy, and Marathon Digital experienced synchronized declines alongside the Bitcoin selloff, indicating broad-based weakness across the cryptocurrency equity complex driven by macroeconomic and geopolitical headwinds.
- • Bitcoin ETF inflows have flattened amid the broader risk-off environment, suggesting weakening retail and institutional demand for cryptocurrency exposure across traditional investment vehicles.
Summary
Core Scientific's equity performance deteriorated sharply as Bitcoin experienced a sustained selloff that dragged cryptocurrency-linked stocks lower across the board. The Texas-based mining and infrastructure company, which returned to public markets on the Nasdaq following its 2022 IPO, faced downward pressure on its share price amid the broader digital asset decline. Bitcoin fell to near four-month lows below $80,000 and subsequently descended into the mid-$60,000 range, the lowest level since February, triggering a cascade of losses through crypto-adjacent equities.
The company's vulnerability to Bitcoin price swings stems partly from its substantial digital asset holdings and its operational leverage to cryptocurrency mining economics. As of December 31, 2025, Core Scientific held approximately 2,537 bitcoins on its balance sheet. However, the company had been executing an aggressive Bitcoin liquidation program, reducing holdings to fewer than 1,000 BTC by early 2026, with management planning to fully exit remaining positions during the first quarter of 2026. This liquidation strategy was undertaken to bolster liquidity, reflecting management's strategic shift in focus.
Beyond Bitcoin price exposure, Core Scientific's equity decline was compounded by operational headwinds revealed in fourth-quarter results, which showed a material decline in revenue. Management had announced an acceleration of the company's transformation program, redirecting resources toward AI and high-performance computing colocation services rather than relying primarily on traditional Bitcoin mining operations. This strategic pivot, while potentially valuable long-term, created near-term uncertainty among investors.
The selloff in Core Scientific paralleled broader weakness across the crypto equity complex. Major cryptocurrency-exposed companies including Coinbase, MicroStrategy, and Marathon Digital all experienced significant declines during the same period. The synchronized downturn reflected multiple headwinds: Bitcoin ETF inflows had flattened substantially, geopolitical tensions mounted, and macroeconomic concerns regarding inflation—particularly producer price inflation reaching 6%—weighed on risk assets broadly. This pattern indicated that crypto equities remained highly correlated with Bitcoin spot price movements and broader market risk sentiment despite evolving business models.
The company's vulnerability to Bitcoin price swings stems partly from its substantial digital asset holdings and its operational leverage to cryptocurrency mining economics. As of December 31, 2025, Core Scientific held approximately 2,537 bitcoins on its balance sheet. However, the company had been executing an aggressive Bitcoin liquidation program, reducing holdings to fewer than 1,000 BTC by early 2026, with management planning to fully exit remaining positions during the first quarter of 2026. This liquidation strategy was undertaken to bolster liquidity, reflecting management's strategic shift in focus.
Beyond Bitcoin price exposure, Core Scientific's equity decline was compounded by operational headwinds revealed in fourth-quarter results, which showed a material decline in revenue. Management had announced an acceleration of the company's transformation program, redirecting resources toward AI and high-performance computing colocation services rather than relying primarily on traditional Bitcoin mining operations. This strategic pivot, while potentially valuable long-term, created near-term uncertainty among investors.
The selloff in Core Scientific paralleled broader weakness across the crypto equity complex. Major cryptocurrency-exposed companies including Coinbase, MicroStrategy, and Marathon Digital all experienced significant declines during the same period. The synchronized downturn reflected multiple headwinds: Bitcoin ETF inflows had flattened substantially, geopolitical tensions mounted, and macroeconomic concerns regarding inflation—particularly producer price inflation reaching 6%—weighed on risk assets broadly. This pattern indicated that crypto equities remained highly correlated with Bitcoin spot price movements and broader market risk sentiment despite evolving business models.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.